Vault-13

Boxer Capital, LLC

San Diego, CA · CIK 1465837 · 13F filing filed 2022-08-15

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$1.6bn reported value -18.8% vs Q1 2022
76positions
42.1%in top 10
5 new 1 added 2 reduced 3 sold out vs Q1 2022

Holdings, Q2 2022

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 MIRATI THERAPEUTICS INC COM MRTX MRTX 2,000,000 $134.3m8.50% 8.50% UnchangedShares held: Q3 2021 2.0m, Q4 2021 2.0m, Q1 2022 2.0m, Q2 2022 2.0m
2 CYTOKINETICS INC COM NEW CYTK CYTK 2,100,000 $82.5m5.23% 5.23% UnchangedShares held: Q3 2021 2.1m, Q4 2021 2.1m, Q1 2022 2.1m, Q2 2022 2.1m
3 BEIGENE LTD SPONSORED ADR ONC ONC 500,000 $80.9m5.13% 5.13% UnchangedShares held: Q3 2021 764.2k, Q4 2021 500.0k, Q1 2022 500.0k, Q2 2022 500.0k
4 REVOLUTION MEDICINES INC COM RVMD RVMD 3,484,264 $67.9m4.30% 4.30% UnchangedShares held: Q3 2021 3.5m, Q4 2021 3.5m, Q1 2022 3.5m, Q2 2022 3.5m
5 APELLIS PHARMACEUTICALS INC COM APLS APLS 1,303,700 $59.0m3.73% 3.73% UnchangedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 1.3m, Q2 2022 1.3m
6 SPRINGWORKS THERAPEUTICS INC COM SWTX SWTX 2,075,905 $51.1m3.24% 3.24% UnchangedShares held: Q3 2021 2.1m, Q4 2021 2.1m, Q1 2022 2.1m, Q2 2022 2.1m
7 PMV PHARMACEUTICALS INC COM PMVP PMVP 3,498,636 $49.9m3.16% 3.16% UnchangedShares held: Q3 2021 2.3m, Q4 2021 2.8m, Q1 2022 3.5m, Q2 2022 3.5m
8 PROMETHEUS BIOSCIENCES INC COM COM 1,714,000 $48.4m3.06% 3.06% UnchangedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 1.7m, Q2 2022 1.7m
9 TYRA BIOSCIENCES INC COM TYRA TYRA 6,448,359 $46.1m2.92% 2.92% UnchangedShares held: Q3 2021 6.3m, Q4 2021 6.4m, Q1 2022 6.4m, Q2 2022 6.4m
10 RELAY THERAPEUTICS INC COM RLAY RLAY 2,669,132 $44.7m2.83% 2.83% UnchangedShares held: Q3 2021 1.3m, Q4 2021 2.7m, Q1 2022 2.7m, Q2 2022 2.7m
11 ITEOS THERAPEUTICS INC COM ITOS ITOS 2,154,058 $44.4m2.81% 2.81% ReducedShares held: Q3 2021 4.3m, Q4 2021 4.3m, Q1 2022 3.2m, Q2 2022 2.2m -1.0m -1,038,000 -32.5%
12 MERUS N V COM MRUS MRUS 1,900,000 $43.0m2.72% 2.72% UnchangedShares held: Q3 2021 1.9m, Q4 2021 1.9m, Q1 2022 1.9m, Q2 2022 1.9m
13 TURNING POINT THERAPEUTICS I COM COM 570,745 $42.9m2.72% 2.72% AddedShares held: Q3 2021 525.0k, Q4 2021 0, Q1 2022 400.0k, Q2 2022 570.7k +170.7k +170,745 42.7%
14 AMYLYX PHARMACEUTICALS INC COM AMLX AMLX 2,200,000 $42.4m2.68% 2.68% UnchangedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 2.2m, Q2 2022 2.2m
15 REATA PHARMACEUTICALS INC CL A RETA RETA 1,239,000 $37.7m2.38% 2.38% UnchangedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 1.2m, Q2 2022 1.2m
16 SPDR SER TR S&P BIOTECH XBI XBI 500,000 $37.1m2.35% 2.35% ReducedShares held: Q3 2021 0, Q4 2021 2.2m, Q1 2022 700.0k, Q2 2022 500.0k -200.0k -200,000 -28.6%
17 ARCUS BIOSCIENCES INC COM RCUS RCUS 1,432,200 $36.3m2.30% 2.30% UnchangedShares held: Q3 2021 2.1m, Q4 2021 1.4m, Q1 2022 1.4m, Q2 2022 1.4m
18 SAGE THERAPEUTICS INC COM SAGE SAGE 1,094,000 $35.3m2.24% 2.24% UnchangedShares held: Q3 2021 1.1m, Q4 2021 1.1m, Q1 2022 1.1m, Q2 2022 1.1m
19 TANGO THERAPEUTICS INC COM TNGX TNGX 6,871,642 $31.1m1.97% 1.97% UnchangedShares held: Q3 2021 6.9m, Q4 2021 6.9m, Q1 2022 6.9m, Q2 2022 6.9m
20 IDEAYA BIOSCIENCES INC COM IDYA IDYA 2,202,812 $30.4m1.93% 1.93% UnchangedShares held: Q3 2021 2.2m, Q4 2021 2.2m, Q1 2022 2.2m, Q2 2022 2.2m
21 BELLUS HEALTH INC NEW COM NEW BLU BLU 3,200,000 $29.6m1.87% 1.87% UnchangedShares held: Q3 2021 3.0m, Q4 2021 3.2m, Q1 2022 3.2m, Q2 2022 3.2m
22 ANAPTYSBIO INC COM ANAB ANAB 1,300,000 $26.4m1.67% 1.67% UnchangedShares held: Q3 2021 1.3m, Q4 2021 1.3m, Q1 2022 1.3m, Q2 2022 1.3m
23 BLUEPRINT MEDICINES CORP COM BPMC BPMC 507,374 $25.6m1.62% 1.62% UnchangedShares held: Q3 2021 425.0k, Q4 2021 507.4k, Q1 2022 507.4k, Q2 2022 507.4k
24 AMICUS THERAPEUTICS INC COM FOLD FOLD 2,325,000 $25.0m1.58% 1.58% UnchangedShares held: Q3 2021 2.3m, Q4 2021 2.3m, Q1 2022 2.3m, Q2 2022 2.3m
25 KINNATE BIOPHARMA INC COM KNTE KNTE 1,847,559 $23.3m1.48% 1.48% UnchangedShares held: Q3 2021 1.8m, Q4 2021 1.8m, Q1 2022 1.8m, Q2 2022 1.8m
26 IOVANCE BIOTHERAPEUTICS INC COM IOVA IOVA 1,935,133 $21.4m1.35% 1.35% UnchangedShares held: Q3 2021 1.1m, Q4 2021 1.1m, Q1 2022 1.9m, Q2 2022 1.9m
27 DAY ONE BIOPHARMACEUTICALS I COM COM 1,189,943 $21.3m1.35% 1.35% UnchangedShares held: Q3 2021 1.2m, Q4 2021 1.2m, Q1 2022 1.2m, Q2 2022 1.2m
28 GOSSAMER BIO INC COM GOSS GOSS 2,462,358 $20.6m1.31% 1.31% UnchangedShares held: Q3 2021 2.5m, Q4 2021 2.5m, Q1 2022 2.5m, Q2 2022 2.5m
29 ROCKET PHARMACEUTICALS INC COM RCKT RCKT 1,466,051 $20.2m1.28% 1.28% UnchangedShares held: Q3 2021 1.5m, Q4 2021 1.5m, Q1 2022 1.5m, Q2 2022 1.5m
30 XENON PHARMACEUTICALS INC COM XENE XENE 600,000 $18.3m1.16% 1.16% UnchangedShares held: Q3 2021 857.0k, Q4 2021 600.0k, Q1 2022 600.0k, Q2 2022 600.0k
31 ACADIA PHARMACEUTICALS INC COM ACAD ACAD 1,263,930 $17.8m1.13% 1.13% UnchangedShares held: Q3 2021 0, Q4 2021 185.0k, Q1 2022 1.3m, Q2 2022 1.3m
32 POINT BIOPHARMA GLOBAL INC COM COM 2,500,000 $17.0m1.08% 1.08% UnchangedShares held: Q3 2021 2.5m, Q4 2021 2.5m, Q1 2022 2.5m, Q2 2022 2.5m
33 NUVALENT INC COM COM 1,210,192 $16.4m1.04% 1.04% UnchangedShares held: Q3 2021 1.2m, Q4 2021 1.2m, Q1 2022 1.2m, Q2 2022 1.2m
34 AVIDITY BIOSCIENCES INC COM RNA RNA 1,121,327 $16.3m1.03% 1.03% UnchangedShares held: Q3 2021 1.1m, Q4 2021 1.1m, Q1 2022 1.1m, Q2 2022 1.1m
35 NURIX THERAPEUTICS INC COM NRIX NRIX 1,224,892 $15.5m0.98% 0.98% UnchangedShares held: Q3 2021 1.2m, Q4 2021 1.2m, Q1 2022 1.2m, Q2 2022 1.2m
36 SAREPTA THERAPEUTICS INC COM SRPT SRPT 200,000 $15.0m0.95% 0.95% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 200.0k
37 BIOMEA FUSION INC COM BMEA BMEA 1,188,405 $14.2m0.90% 0.90% UnchangedShares held: Q3 2021 2.1m, Q4 2021 1.2m, Q1 2022 1.2m, Q2 2022 1.2m
38 NUVATION BIO INC COM CL A NUVB NUVB 4,341,009 $14.1m0.89% 0.89% UnchangedShares held: Q3 2021 4.3m, Q4 2021 4.3m, Q1 2022 4.3m, Q2 2022 4.3m
39 CULLINAN THERAPEUTICS INC COM CGEM CGEM 1,074,082 $13.8m0.87% 0.87% UnchangedShares held: Q3 2021 1.1m, Q4 2021 1.1m, Q1 2022 1.1m, Q2 2022 1.1m
40 MILESTONE PHARMACEUTICALS IN COM MIST MIST 2,238,861 $13.8m0.87% 0.87% UnchangedShares held: Q3 2021 2.6m, Q4 2021 2.2m, Q1 2022 2.2m, Q2 2022 2.2m
41 FATE THERAPEUTICS INC COM FATE FATE 500,000 $12.4m0.78% 0.78% UnchangedShares held: Q3 2021 0, Q4 2021 500.0k, Q1 2022 500.0k, Q2 2022 500.0k
42 GH RESEARCH PLC ORDINARY SHARES GHRS GHRS 1,013,399 $10.1m0.64% 0.64% UnchangedShares held: Q3 2021 1.0m, Q4 2021 1.0m, Q1 2022 1.0m, Q2 2022 1.0m
43 PROTHENA CORP PLC SHS PRTA PRTA 300,000 $8.1m0.52% 0.52% UnchangedShares held: Q3 2021 300.0k, Q4 2021 300.0k, Q1 2022 300.0k, Q2 2022 300.0k
44 AKERO THERAPEUTICS INC COM AKRO AKRO 831,495 $7.9m0.50% 0.50% UnchangedShares held: Q3 2021 831.5k, Q4 2021 831.5k, Q1 2022 831.5k, Q2 2022 831.5k
45 RAIN ONCOLOGY INC COM COM 1,175,000 $6.5m0.41% 0.41% UnchangedShares held: Q3 2021 1.2m, Q4 2021 1.2m, Q1 2022 1.2m, Q2 2022 1.2m
46 ASCENDIS PHARMA A/S SPONSORED ADR SPONSORED ADR 70,000 $6.5m0.41% 0.41% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 70.0k
47 NGM BIOPHARMACEUTICALS INC COM NGM NGM 500,000 $6.4m0.41% 0.41% UnchangedShares held: Q3 2021 500.0k, Q4 2021 500.0k, Q1 2022 500.0k, Q2 2022 500.0k
48 CENTESSA PHARMACEUTICALS PLC SPONSORED ADS SPONSORED ADS 1,251,137 $6.1m0.39% 0.39% UnchangedShares held: Q3 2021 1.3m, Q4 2021 1.3m, Q1 2022 1.3m, Q2 2022 1.3m
49 2SEVENTY BIO INC COMMON STOCK TSVT TSVT 459,836 $6.1m0.38% 0.38% UnchangedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 459.8k, Q2 2022 459.8k
50 DBV TECHNOLOGIES S A SPONSORED ADR SPONSORED ADR 2,134,598 $5.4m0.34% 0.34% UnchangedShares held: Q3 2021 7.5m, Q4 2021 2.1m, Q1 2022 2.1m, Q2 2022 2.1m
51 BLACK DIAMOND THERAPEUTICS I COM BDTX BDTX 2,014,858 $5.0m0.31% 0.31% UnchangedShares held: Q3 2021 2.0m, Q4 2021 2.0m, Q1 2022 2.0m, Q2 2022 2.0m
52 BCLS ACQUISITION CORP COM CL A COM CL A 500,000 $5.0m0.31% 0.31% UnchangedShares held: Q3 2021 500.0k, Q4 2021 500.0k, Q1 2022 500.0k, Q2 2022 500.0k
53 THESEUS PHARMACEUTICALS INC COM COM 892,057 $4.9m0.31% 0.31% UnchangedShares held: Q3 2021 0, Q4 2021 892.1k, Q1 2022 892.1k, Q2 2022 892.1k
54 PANACEA ACQUISITION CORP II CL A SHS CL A SHS 500,000 $4.9m0.31% 0.31% UnchangedShares held: Q3 2021 500.0k, Q4 2021 500.0k, Q1 2022 500.0k, Q2 2022 500.0k
55 ORIC PHARMACEUTICALS INC COM ORIC ORIC 1,054,000 $4.7m0.30% 0.30% UnchangedShares held: Q3 2021 200.0k, Q4 2021 200.0k, Q1 2022 1.1m, Q2 2022 1.1m
56 EQRX INC COM COM 1,000,000 $4.7m0.30% 0.30% UnchangedShares held: Q3 2021 0, Q4 2021 1.0m, Q1 2022 1.0m, Q2 2022 1.0m
57 89BIO INC COM ETNB ETNB 1,400,000 $4.5m0.29% 0.29% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 1.4m
58 SELECTA BIOSCIENCES INC COM COM 3,284,072 $4.3m0.27% 0.27% UnchangedShares held: Q3 2021 3.3m, Q4 2021 3.3m, Q1 2022 3.3m, Q2 2022 3.3m
59 HEALTH SCIENCES ACQ CORP 2 ORD SHS OBIO OBIO 400,000 $4.0m0.25% 0.25% UnchangedShares held: Q3 2021 400.0k, Q4 2021 400.0k, Q1 2022 400.0k, Q2 2022 400.0k
60 ATRECA INC CL A COM BCEL BCEL 2,202,333 $3.9m0.25% 0.25% UnchangedShares held: Q3 2021 2.2m, Q4 2021 2.2m, Q1 2022 2.2m, Q2 2022 2.2m
61 COGENT BIOSCIENCES INC COM COGT COGT 425,000 $3.8m0.24% 0.24% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 425.0k
62 SOLID BIOSCIENCES INC COM COM 5,336,031 $3.3m0.21% 0.21% UnchangedShares held: Q3 2021 3.7m, Q4 2021 3.2m, Q1 2022 5.3m, Q2 2022 5.3m
63 MEREO BIOPHARMA GROUP PLC SPON ADS MREO MREO 2,250,000 $2.5m0.16% 0.16% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 2.2m
64 CODIAK BIOSCIENCES INC COM CDAK CDAK 850,065 $2.4m0.16% 0.16% UnchangedShares held: Q3 2021 1.0m, Q4 2021 850.1k, Q1 2022 850.1k, Q2 2022 850.1k
65 ESSA PHARMA INC COM NEW EPI EPI 724,500 $2.3m0.14% 0.14% UnchangedShares held: Q3 2021 687.0k, Q4 2021 724.5k, Q1 2022 724.5k, Q2 2022 724.5k
66 GEMINI THERAPEUTICS INC COM COM 1,300,000 $2.2m0.14% 0.14% UnchangedShares held: Q3 2021 1.3m, Q4 2021 1.3m, Q1 2022 1.3m, Q2 2022 1.3m
67 OMEGA ALPHA SPAC CL A CL A 200,000 $2.0m0.12% 0.12% UnchangedShares held: Q3 2021 200.0k, Q4 2021 200.0k, Q1 2022 200.0k, Q2 2022 200.0k
68 BIOATLA INC COM BCAB BCAB 686,347 $2.0m0.12% 0.12% UnchangedShares held: Q3 2021 686.3k, Q4 2021 686.3k, Q1 2022 686.3k, Q2 2022 686.3k
69 ALIGOS THERAPEUTICS INC COM COM 1,526,048 $1.8m0.12% 0.12% UnchangedShares held: Q3 2021 1.5m, Q4 2021 1.5m, Q1 2022 1.5m, Q2 2022 1.5m
70 MEI PHARMA INC COM NEW MEIP MEIP 2,913,091 $1.8m0.11% 0.11% UnchangedShares held: Q3 2021 2.9m, Q4 2021 2.9m, Q1 2022 2.9m, Q2 2022 2.9m
71 ELEVATION ONCOLOGY INC COM COM 872,780 $1.2m0.08% 0.08% UnchangedShares held: Q3 2021 1.3m, Q4 2021 872.8k, Q1 2022 872.8k, Q2 2022 872.8k
72 PROTARA THERAPEUTICS INC COM STK TARA TARA 209,227 $613.0k0.04% 0.04% UnchangedShares held: Q3 2021 209.2k, Q4 2021 209.2k, Q1 2022 209.2k, Q2 2022 209.2k
73 CABALETTA BIO INC COM CABA CABA 540,000 $572.0k0.04% 0.04% UnchangedShares held: Q3 2021 1.6m, Q4 2021 540.0k, Q1 2022 540.0k, Q2 2022 540.0k
74 NUVATION BIO INC *W EXP 07/07/202 NUVB.WS NUVB.WS 266,666 $75.0k0.00% 0.00% UnchangedShares held: Q3 2021 266.7k, Q4 2021 266.7k, Q1 2022 266.7k, Q2 2022 266.7k
75 BELLICUM PHARMACEUTICALS INC COM NEW BLCM BLCM 56,950 $68.0k0.00% 0.00% UnchangedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 57.0k, Q2 2022 57.0k
76 SURROZEN INC *W EXP 08/01/203 *W EXP 08/01/203 66,666 $13.0k0.00% 0.00% UnchangedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 66.7k, Q2 2022 66.7k

Sold out since Q1 2022

SecurityTickerShares held beforeValue then
ULTRAGENYX PHARMACEUTICAL IN RARE RARE 200,000 $14.5m200.0k shares
ODONATE THERAPEUTICS INC 4,207,086 $5.6m4.2m shares
GENOCEA BIOSCIENCES INC GNCAQ GNCAQ 1,134,453 $1.4m1.1m shares